Morinaga Milk Industry Co., Ltd. announced that its probiotic strain Bifidobacterium breve B-3 has been approved by South Korea for its efficacy in reducing body fat. This Individual Recognized Registration (No. 2023-2) validates the strain’s safety, functionality, and regulatory compliance. Clinical Benefits of B. breve B-3 B. breve B-3, developed by Morinaga Milk, is known […]
Morinaga Milk Industry Co., Ltd., a Japanese dairy product leader, received approval from the Brazilian Health Regulatory Agency (ANVISA) for its Bifidobacterium longum BB536. The approval, effective July 27, 2023, enables the use of the probiotic strain in dietary supplements and conventional foods in Brazil. The strain has now been added to ANVISA’s list of […]
